Topical corticosteroid reforms adjuvant capecitabine chemotherapy. (T-CRACC STUDY)
Phase 2
Recruiting
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-jRCTs031220002
- Lead Sponsor
- Boku Narikazu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Colorectal cancer patients undergoing adjuvant capecitabine and oxaliplatin therapy
Exclusion Criteria
Patients with contraindications for the administration of hydrocortisone topical
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method